> Last Item Added:
0 Items

New Magnetic Bead Format Improves Automation Compatibility of Multiplex Assays

Billerica, Massachusetts—January 18, 2010— Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools, and services for the global life science industry, today announced the introduction of a new suite of multiplex assays that use magnetic beads for more consistent results and automation compatibility. Designed for use with Luminex® xMAP® technology, these new MILLIPLEX® MAG kits complement Millipore’s broad selection of non-magnetic multiplex assays and enable researchers to choose the format they prefer.

MILLIPLEX MAG kits include microspheres embedded with superparamagnetic particles. Once bound to the protein of interest, the microspheres can be magnetically separated. This makes sample preparation easier and eliminates the risk of sample loss, clogs, or leaks. The new kits also reduce non-specific binding, which results in lower, more consistent coefficients of variation (CVs).

“Magnetic bead technology is making multiplex assays more efficient than ever,” said Cindy Fry, MILLIPLEX product manager. “Over time, it is expected that magnetic microspheres will replace polystyrene for Luminex-based assays. By offering a choice of formats for our most popular assays, we are giving our customers time to transition to the new format.”

Both the magnetic and non-magnetic MILLIPLEX kits use the same protocols and components (except for the beads), so researchers do not need to re-optimize their methods when switching from one format to another.

To date, seven MILLIPLEX MAG kits have been released, including kits for cytokine and chemokine research and metabolic disease research. A significant portion of the existing MILLIPLEX line will be available in both magnetic and non-magnetic formats by the end of 2010.

Multiplexing allows quick, accurate analysis of multiple proteins simultaneously. It is especially useful for analysis of complex events such as protein-protein interactions, cell signaling pathways, and metabolic processes.

Additional Resources
http://www.millipore.com/drugdiscovery/dd2/mag
Download High Resolution Image
http://www.millipore.com/press/files/external_press/$file/millipore_milliplex.jpg



About Millipore:

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER
®
Research. Development. Production.


Millipore Media Contact:

Greg Hoff
Media Relations
Bioscience Division
978-762-5170
greg_hoff@millipore.com


Millipore, Advancing Life Science Together, and MILLIPLEX are registered trademarks of Millipore Corporation. The “M” logo is a trademark of Millipore Corporation. Luminex and xMAP are registered trademarks of Luminex Corporation.

Find A Location

Find the Millipore office or expert closest to you.

Contact Us

We want to hear from you. Contact a specific department below or click "Suggestions and Feedback" to send your comments.